Home » Topics » Regulatory » Patents

Patents
RSS

Northwestern University reports development of APOBEC-3G expression enhancers

March 15, 2016

UCL Business discloses cyclophilin D inhibitors

March 15, 2016

Japanese scientists patent E-NPP 2 inhibitors

March 15, 2016

University of Virginia reports RUNX1 inhibitors

March 14, 2016

Sunnylife Pharma presents 5-HT2C receptor agonists

March 14, 2016

EpiTherapeutics describes lysine-specific demethylase inhibitors

March 14, 2016

Astellas Pharma discloses muscarinic M3 receptor PAMs

March 14, 2016

Takeda Pharmaceutical patents HDAC6 inhibitors

March 14, 2016

University of Dayton reports antineoplastic and antibacterial compounds

March 11, 2016

Bristol-Myers Squibb describes HIV integrase inhibitors

March 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...